The Essential Guide to the Role of the UK Responsible Person (UKRP) for Foreign Medical Device Manufacturers

Entering the UK medical device market requires more than just a quality product. For foreign medical device manufacturers, understanding and complying with UK regulations is critical. One key requirement under the UK Medical Devices Regulations 2002, as amended, is the appointment of a UK Responsible Person (UKRP). This role acts as the manufacturer’s representative in Great Britain, ensuring smooth regulatory communication and compliance with UK authorities, primarily the MHRA (Medicines and Healthcare products Regulatory Agency).

This guide explains who needs a UK Responsible Person, when it is required, the documentation involved, and why partnering with an experienced regulatory consultant like AF Pharma can make a significant difference in achieving successful UK medical device registration and market access.

UK Responsible Person managing medical device regulatory documents

Who Needs a UK Responsible Person (UKRP)?

Any foreign medical device manufacturer UK aiming to place medical devices on the Great Britain market must appoint a UK Responsible Person. This includes manufacturers based outside the UK and Northern Ireland. The UKRP acts as the official UK-based contact for the MHRA and is responsible for ensuring compliance with the UK Medical Devices Regulations 2002.

Manufacturers who do not have a physical presence in the UK cannot directly register their devices with the MHRA or handle post-market obligations. The UKRP fills this gap by:

• Acting as the manufacturer’s representative for MHRA registration and regulatory communication

• Maintaining access to technical documentation within the UK

• Supporting post-market activities such as vigilance and post-market surveillance UK

  
  

This requirement applies to all medical devices, including those requiring UKCA marking for conformity assessment.

When Is a UK Responsible Person Required (UKRP)?

The appointment of a UKRP is mandatory when a foreign manufacturer intends to place medical devices on the Great Britain market. This includes:

• New device registrations after Brexit, as the UK now operates a separate regulatory system from the EU

• Devices already on the market that require updated registration or compliance with UK-specific rules

• Products needing UKCA marking to demonstrate conformity with UK regulations

  
  

The UKRP must be appointed before submitting any registration to the MHRA. Without a UKRP, foreign manufacturers cannot legally market their devices in Great Britain.

What Documents Are Usually Needed?

The UK Responsible Person supports the manufacturer by ensuring all necessary documentation is in order for UK medical device registration and ongoing compliance. Key documents typically include:

• Declaration of Conformity review confirming the device meets UK regulatory requirements

• Technical documentation demonstrating safety and performance, including design, manufacturing, and clinical data (technical documentation review)

• Certificates issued by UK-recognised conformity assessment bodies

• Product labelling and instructions for use (IFU review), which may need to include UKRP details depending on the device and timelines

• GMDN codes and Basic UDI-DI / UDI information for device identification and traceability

• Post-market surveillance plans and vigilance reports to comply with medical device vigilance UK obligations

  
  

The UKRP ensures these documents are accessible to the MHRA and supports manufacturers in maintaining compliance throughout the product lifecycle.

Why It Is Important to Appoint an Experienced Regulatory Partner

Choosing the right UKRP is crucial. The role requires detailed knowledge of the UK Medical Devices Regulations 2002, MHRA processes, and post-market requirements. An experienced medical device compliance consultant UK like AF Pharma offers several advantages:

• Expert guidance on MHRA registration and regulatory strategy for the UK market

• Thorough review of all technical documentation, labels, IFUs, and declarations to ensure compliance

• Support with medical device UK market access including UKCA marking transition strategies

• Assistance with post-market surveillance, vigilance reporting, and corrective actions

• Acting as a reliable liaison with MHRA medical devices teams for smooth communication and issue resolution

  
  

AF Pharma’s UK responsible person service helps manufacturers, startups, and SMEs navigate complex regulatory requirements efficiently, reducing risks and accelerating time to market.

Practical Examples of AF Pharma Support

AF Pharma provides comprehensive support tailored to the needs of foreign manufacturers entering the UK market. Examples include:

• Assisting with MHRA device registration submissions, ensuring all forms and documents meet regulatory expectations

• Reviewing and advising on the Declaration of Conformity review to confirm alignment with UK regulations

• Checking product labels and IFUs for inclusion of UKRP details where required, helping manufacturers comply with labelling rules

• Conducting detailed technical documentation review to verify completeness and accuracy

• Advising on GMDN codes and UDI requirements to support device identification and traceability

• Supporting post-market surveillance UK activities, including vigilance reporting and handling complaints or corrective actions

• Acting as the official UK contact for MHRA queries, inspections, and audits

  
  

This hands-on approach ensures manufacturers meet all obligations under the UK Medical Devices Regulations 2002 and maintain ongoing compliance.

Understanding UK Medical Device Compliance and Market Access

The UK regulatory landscape has evolved since Brexit, making it essential for foreign manufacturers to understand the differences between EU and UK systems. The appointment of a UKRP is a cornerstone of UK medical device compliance and a legal requirement for market access.

Manufacturers must also plan for UKCA marking, which replaces the CE mark for Great Britain. The UKRP plays a vital role in supporting conformity assessment and ensuring devices carry the correct marking.

By working with a trusted partner like AF Pharma, manufacturers gain clarity on regulatory pathways, reduce administrative burdens, and improve their chances of successful market entry.

Medical device manufacturers aiming to enter the UK market face complex regulatory challenges. Appointing a knowledgeable UK Responsible Person is not just a legal formality but a strategic step to ensure compliance, smooth communication with the MHRA, and ongoing product safety. AF Pharma’s expertise in UK medical device registration, MHRA registration, and post-market support makes it an ideal partner for foreign manufacturers seeking reliable UK regulatory representative services.

For manufacturers ready to navigate the UK regulatory environment confidently, partnering with AF Pharma offers practical, hands-on support that simplifies compliance and accelerates medical device UK market access.